# Regeneron Pharmaceuticals Inc - Inspection Records

Source: https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/cd765cfa-95e6-4023-ade2-0ffa382fe2c7

> Inspection records and compliance data for Regeneron Pharmaceuticals Inc in Rensselaer, New York. Access full analysis and detailed observations.

---

## Details

- Name: Regeneron Pharmaceuticals Inc
- FEI Number: 1000514603
- City: Rensselaer
- State: New York
- Country Name: United States
- Address Line 1: 81 Columbia Tpke
- Zip Code: 12144

## Related Documents

- [483 - Regeneron Pharmaceuticals Inc - Unknown Date](https://www.keypedia.com/records/483/regeneron-pharmaceuticals-inc/44a88309-88ee-461c-a886-71549b687a8c) — source: FDA, date: Invalid Date
- [483 - Regeneron Pharmaceuticals Inc - 2024-03-22](https://www.keypedia.com/records/483/regeneron-pharmaceuticals-inc/42489734-29a2-46d5-96fb-7559354403d0) — source: FDA, date: March 22, 2024
- [FDA Inspection 1230565 - Regeneron Pharmaceuticals Inc - 2024-03-22](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/7df63927-1928-4995-8887-1541aa1d5420) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 22, 2024
- [FDA Inspection 1239760 - Regeneron Pharmaceuticals Inc - 2024-02-16](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/be92bc21-d599-4a82-9b9d-dde944acebd3) — source: FDA, date: February 16, 2024
- [483 - Regeneron Pharmaceuticals Inc - 2021-10-25](https://www.keypedia.com/records/483/regeneron-pharmaceuticals-inc/5edf66c0-5435-47f5-8b9c-95bb5b5aa87c) — source: FDA, date: October 25, 2021
- [FDA Inspection 1155063 - Regeneron Pharmaceuticals Inc - 2021-10-25](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/f2f814f1-cd34-4b8c-9b74-fb3e6156fa2d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 25, 2021
- [EIR - Regeneron Pharmaceuticals Inc - 2019-10-18](https://www.keypedia.com/records/eir/regeneron-pharmaceuticals-inc/2f21fa9c-603b-4c48-adf9-570ec85676b9) — source: FDA, date: October 18, 2019
- [483 - Regeneron Pharmaceuticals Inc - 2019-10-18](https://www.keypedia.com/records/483/regeneron-pharmaceuticals-inc/cdc34046-95b0-4b53-851f-dfbbdefa15ff) — source: FDA, date: October 18, 2019
- [FDA Inspection 1106821 - Regeneron Pharmaceuticals Inc - 2019-10-18](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/2d3aca16-4c83-4b48-914c-5f89d3ad6cde) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 18, 2019
- [EIR - Regeneron Pharmaceuticals Inc - 2018-06-08](https://www.keypedia.com/records/eir/regeneron-pharmaceuticals-inc/81a20693-7265-4381-9e44-5d937815704f) — source: FDA, date: June 8, 2018
- [FDA Inspection 1030807 - Regeneron Pharmaceuticals Inc - 2017-10-05](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/9fbb9269-f14d-4a71-a17c-ebb14c24aed4) — classification: No Action Indicated (NAI), source: FDA, date: October 5, 2017
- [FDA Inspection 983604 - Regeneron Pharmaceuticals Inc - 2016-08-19](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/caf7d10a-59bc-40a1-b6f6-8e3e13e51b49) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 19, 2016
- [FDA Inspection 883187 - Regeneron Pharmaceuticals Inc - 2014-06-13](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/941cd0fe-03ff-4f46-b6c4-dee6022f079a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 13, 2014
- [FDA Inspection 848983 - Regeneron Pharmaceuticals Inc - 2013-05-24](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/0bfe609a-c29d-4ce4-98c6-7487de2cd53b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 24, 2013
- [FDA Inspection 786188 - Regeneron Pharmaceuticals Inc - 2012-06-08](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/6098395f-e261-4105-b03e-7de744347073) — classification: No Action Indicated (NAI), source: FDA, date: June 8, 2012
- [FDA Inspection 736962 - Regeneron Pharmaceuticals Inc - 2011-07-29](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/b2640f5e-4470-460b-99b3-1c9739231ce8) — classification: No Action Indicated (NAI), source: FDA, date: July 29, 2011

## Related Companies

- [BSP Pharmaceuticals SpA](https://www.keypedia.com/companies/bsp-pharmaceuticals-spa/cbf52ec3-50e2-4cf1-9f81-f0f7a74473fc)
- [Wyeth Pharmaceutical Division of Wyeth Holdings LLC](https://www.keypedia.com/companies/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/85fd73c7-1b97-4ac5-bc70-53dfb31c37e5)
- [Laurus Labs Limited](https://www.keypedia.com/companies/laurus-labs-limited/4112e7fd-7d8d-41bc-914f-6c705b2e47c7)
- [Sanofi Winthrop Industrie](https://www.keypedia.com/companies/sanofi-winthrop-industrie/f7668868-7954-441c-b8bf-ab135e8645c2)
- [Takeda Manufacturing Italia SPA](https://www.keypedia.com/companies/takeda-manufacturing-italia-spa/1998fa46-5f10-426b-b959-5378f2b887e1)
- [Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a)
- [Rentschler Biopharma SE](https://www.keypedia.com/companies/rentschler-biopharma-se/da50fa41-24f6-449f-bf90-45eccb97d9ba)
- [Abbvie Biotechnology Ltd.](https://www.keypedia.com/companies/abbvie-biotechnology-ltd/b438b15a-033c-469a-8973-66b6506bba41)
- [Purolea Cosmetics Lab](https://www.keypedia.com/companies/purolea-cosmetics-lab/a2662a80-cd8c-4da0-bd8d-6cd4ea6079c6)
- [Chugai Pharma Manufacturing Co. Ltd.](https://www.keypedia.com/companies/chugai-pharma-manufacturing-co-ltd/09ba6515-9227-444c-a24c-a6cb8da9e235)

## Related Officers

- [CDR Paul N. Thompson, Investigator](https://www.keypedia.com/people/cdr-paul-n-thompson-investigator/7c0bf160-49f0-4d97-b7aa-f78654fe7511)
- [J. Paul Kirwan, Ph.D., Staff Fellow](https://www.keypedia.com/people/j-paul-kirwan-phd-staff-fellow/c5c1f40b-e115-48fe-8c47-1ad2fb61823a)
- [issuing_officer](https://www.keypedia.com/people/patricia-f-hughes-troost/11f80c43-380b-47a5-a389-1bad9093fd65)
- [investigator](https://www.keypedia.com/people/jens-fricke/4d47c4b1-cc92-4c0d-8b63-00bb4b18e443)
- [Consumer Safety Officer Drug Specialist](https://www.keypedia.com/people/sony-mathews/4d42379f-1245-494c-8c19-6cefa4e560a5)
- [Mindy M. Chou](https://www.keypedia.com/people/mindy-m-chou/3d0e74bf-ad6b-48b5-8b72-cbb29e9c9ce5)